Liliana E. Pezzin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liliana E. Pezzin has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Ann Butler Nattinger
Department of Medicine, Medical College of Wisconsin, Milwaukee
8 shared publications - Timothy R. Dillingham
Department of Physical Medicine and Rehabilitation, University of Pennsylvania, Philadelphia, Pennsylvania
6 shared publications - Jibby E. Kurichi
Department of Biostatistics and Epidemiology, The Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
4 shared publications - Adam I. Edelstein
Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
3 shared publications Dawei Xie
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3 shared publicationsEmily L. McGinley
Center for Advancing Population Science Medical College of Wisconsin Milwaukee Wisconsin USA
3 shared publications
Latest Publications
- Open Access
- 22 June 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14 (1) , e85803
Pre-Amyloidosis Red-Flag Clinical Diagnoses in Light Chain (AL) Versus Age-Related Transthyretin (ATTRwt) Amyloidosis: Electronic Health Record–Based Descriptive Study
This electronic health record–based study highlights distinct diagnostic patterns preceding a diagnosis of light chain (AL) and wild-type transthyretin (ATTRwt) amyloidosis; AL amyloidosis was more frequently preceded by renal, gastrointestinal, neurologic, and clonal plasma cell disorders, whereas ATTRwt amyloidosis was more commonly associated with cardiac manifestations and carpal tunnel syndrome.
- 22 June 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14 (1) , e85803
Open AccessPre-Amyloidosis Red-Flag Clinical Diagnoses in Light Chain (AL) Versus Age-Related Transthyretin (ATTRwt) Amyloidosis: Electronic Health Record–Based Descriptive Study
This electronic health record–based study highlights distinct diagnostic patterns preceding a diagnosis of light chain (AL) and wild-type transthyretin (ATTRwt) amyloidosis; AL amyloidosis was more frequently preceded by renal, gastrointestinal, neurologic, and clonal plasma cell disorders, whereas ATTRwt amyloidosis was more commonly associated with cardiac manifestations and carpal tunnel syndrome.
Does regionalization of initial breast cancer care delay time to surgery?
Background: By leveraging a natural experiment afforded by New York’s 2009 policy restricting Medicaid reimbursement for breast cancer surgery at low‐volume hospitals, this study examined the effect of regionalization on time from breast cancer diagnosis to initial upfront surgery.Methods: By using a linked data set merging New York Cancer Registry and New York facilities’ discharge data, women with stage I–III incident breast cancer during the pre‐ (2004–2008) and postpolicy (2010–2013) periods were identified. Multivariable difference‐in‐difference‐in‐differences models estimated the policy effect on the probability of experiencing delayed care (>60 days) between diagnosis and initial surgery.Results: Among 71,135 women, 12% had Medicaid coverage. Women treated in postpolicy years (p < .001 relative to prepolicy) and Medicaid beneficiaries (p < .001 relative to non‐Medicaid patients) were more likely to experience delayed care. Non‐Medicaid beneficiaries had a 12.6% probability of delayed care postpolicy (compared to 8.8% prepolicy), whereas Medicaid beneficiaries had a 21% probability of delayed care postpolicy (compared to 14.5% prepolicy). Although these increases were not statistically different between the Medicaid and non‐Medicaid groups as a whole, which indicates no overall policy effect, Medicaid beneficiaries in nonurban areas were more likely to experience delayed care after the policy implementation (p = .04).Conclusions: Regionalization of breast cancer care in New York did not lead to a significant overall decrease in access to timely surgical care. Regionalization of care may be a promising approach to improving breast cancer outcomes. However, the potential impact on nonurban and other vulnerable populations must be carefully considered to prevent exacerbating disparities in access to care.
Does regionalization of initial breast cancer care delay time to surgery?
Background: By leveraging a natural experiment afforded by New York’s 2009 policy restricting Medicaid reimbursement for breast cancer surgery at low‐volume hospitals, this study examined the effect of regionalization on time from breast cancer diagnosis to initial upfront surgery.Methods: By using a linked data set merging New York Cancer Registry and New York facilities’ discharge data, women with stage I–III incident breast cancer during the pre‐ (2004–2008) and postpolicy (2010–2013) periods were identified. Multivariable difference‐in‐difference‐in‐differences models estimated the policy effect on the probability of experiencing delayed care (>60 days) between diagnosis and initial surgery.Results: Among 71,135 women, 12% had Medicaid coverage. Women treated in postpolicy years (p < .001 relative to prepolicy) and Medicaid beneficiaries (p < .001 relative to non‐Medicaid patients) were more likely to experience delayed care. Non‐Medicaid beneficiaries had a 12.6% probability of delayed care postpolicy (compared to 8.8% prepolicy), whereas Medicaid beneficiaries had a 21% probability of delayed care postpolicy (compared to 14.5% prepolicy). Although these increases were not statistically different between the Medicaid and non‐Medicaid groups as a whole, which indicates no overall policy effect, Medicaid beneficiaries in nonurban areas were more likely to experience delayed care after the policy implementation (p = .04).Conclusions: Regionalization of breast cancer care in New York did not lead to a significant overall decrease in access to timely surgical care. Regionalization of care may be a promising approach to improving breast cancer outcomes. However, the potential impact on nonurban and other vulnerable populations must be carefully considered to prevent exacerbating disparities in access to care.
The association of multiple sclerosis, traumatic brain injury, and spinal cord injury to acute and long COVID‐19 outcomes
Background: Although persons with disabilities are a high‐risk group, little is known about the association between specific disabling conditions and acute or long COVID outcomes.Objective: To examine the severity of acute SARS‐CoV‐2 infection and post‐COVID outcomes among people with a preexisting diagnosis of multiple sclerosis (MS), spinal cord injury (SCI), or traumatic brain injury (TBI).Methods: This was a retrospective cohort study using the TrinetX Research Database, a large representative database of medical records. COVID‐19‐positive persons with MS, SCI, or TBI (cases) were matched 1:1 on age, gender, race, ethnicity, and comorbidities to COVID‐19‐positive persons without these diagnoses (controls). The main outcomes assessed were hospitalization for acute COVID‐19, length of stay (LOS), the total number of hospitalizations, mortality, and incidence of six prevalent post‐COVID sequelae within 6 months following a COVID‐19 diagnosis.Results: There were 388,297 laboratory‐confirmed COVID‐19 cases identified. Of these cases, 2204 individuals had one of the following preexisting diagnoses: 51.3% TBI, 31.4% MS, and 17.3% SCI. People with TBI, MS, and SCI were significantly more likely to be hospitalized for COVID‐19 (odds ratio [OR] = 1.22, 95% confidence interval [CI] = 1.03–1.46) than matched controls. There was no difference in LOS, total hospitalizations, or mortality during the 6 months following the initial COVID diagnosis. Multivariable analyses reveal that persons with TBI, MS, and SCI were more likely to experience new weakness (OR = 1.54, 95% CI = 1.19–2.00), mobility difficulties (OR = 1.66, 95% CI = 1.17–2.35), and cognitive dysfunction (OR = 1.79, 95% CI = 1.38–2.33) than controls, even after controlling for the presence of these symptoms prior to their COVID infection and other risk factors. There were no differences in fatigue, pain, or dyspnea.Conclusions: Having a history of MS, SCI or TBI was not associated with higher mortality risk from COVID‐19. However, associations between these diagnoses and postacute COVID‐19 symptoms raise concern about widening health outcome disparities for individuals with such potentially disabling conditions following COVID‐19 infection.
The association of multiple sclerosis, traumatic brain injury, and spinal cord injury to acute and long COVID‐19 outcomes
Background: Although persons with disabilities are a high‐risk group, little is known about the association between specific disabling conditions and acute or long COVID outcomes.Objective: To examine the severity of acute SARS‐CoV‐2 infection and post‐COVID outcomes among people with a preexisting diagnosis of multiple sclerosis (MS), spinal cord injury (SCI), or traumatic brain injury (TBI).Methods: This was a retrospective cohort study using the TrinetX Research Database, a large representative database of medical records. COVID‐19‐positive persons with MS, SCI, or TBI (cases) were matched 1:1 on age, gender, race, ethnicity, and comorbidities to COVID‐19‐positive persons without these diagnoses (controls). The main outcomes assessed were hospitalization for acute COVID‐19, length of stay (LOS), the total number of hospitalizations, mortality, and incidence of six prevalent post‐COVID sequelae within 6 months following a COVID‐19 diagnosis.Results: There were 388,297 laboratory‐confirmed COVID‐19 cases identified. Of these cases, 2204 individuals had one of the following preexisting diagnoses: 51.3% TBI, 31.4% MS, and 17.3% SCI. People with TBI, MS, and SCI were significantly more likely to be hospitalized for COVID‐19 (odds ratio [OR] = 1.22, 95% confidence interval [CI] = 1.03–1.46) than matched controls. There was no difference in LOS, total hospitalizations, or mortality during the 6 months following the initial COVID diagnosis. Multivariable analyses reveal that persons with TBI, MS, and SCI were more likely to experience new weakness (OR = 1.54, 95% CI = 1.19–2.00), mobility difficulties (OR = 1.66, 95% CI = 1.17–2.35), and cognitive dysfunction (OR = 1.79, 95% CI = 1.38–2.33) than controls, even after controlling for the presence of these symptoms prior to their COVID infection and other risk factors. There were no differences in fatigue, pain, or dyspnea.Conclusions: Having a history of MS, SCI or TBI was not associated with higher mortality risk from COVID‐19. However, associations between these diagnoses and postacute COVID‐19 symptoms raise concern about widening health outcome disparities for individuals with such potentially disabling conditions following COVID‐19 infection.
Rehabilitation after brain tumor resection: A national study of postacute care service use through insurance claims data
ObjectiveTo assess postacute rehabilitation service use and length of stay among a national sample of patients with brain tumors after surgery.DesignA retrospective review was conducted of health care claims data of a national sample of patients via The Optum Clinformatics DataMart.Setting and ParticipantsThis study included adult individuals (>= 18 years of age) who were diagnosed with a brain tumor between 2015 and 2019 and underwent a craniotomy or craniectomy within 180 days of diagnosis.MethodsDescriptive statistics were used to characterize patients by tumor type. Multivariate models assessed factors associated with discharge setting and length of stay.ResultsOf the 10,275 individuals identified, 69% had malignant tumors. Over two thirds of patients were discharged directly home (with or without home health care) and 9.3% and 9.5% were discharged to acute rehabilitation facilities (inpatient rehabilitation facilities [IRF]) and skilled nursing facilities (SNF/ICF), respectively. About 13.5% were discharged to other settings. The average length of stay during the episode of care was 8.6 (SD = 9.6) days. After adjusting for confounders, individuals with benign brain tumors were more likely to be discharged to either IRF or SNF/ICF than return home after acute care stay, as were those with greater comorbidities, older age, fee-for-service and health maintenance organization insurance. Wealthier patients were less likely to be discharged to a SNF/ICF than home, although income was not a factor affecting discharge to an IRF. Patients with benign tumors, the oldest old (80+), those with more comorbidities as well as Black and Hispanic patients had a longer length of stay during the acute hospitalization.ConclusionsIndividuals with brain tumors have deficits amenable to rehabilitation; however, this study finds that service use differs by tumor type and demographic and socioeconomic factors. Further study is needed to identify if there are barriers to access and use of rehabilitation services in this population.
Rehabilitation after brain tumor resection: A national study of postacute care service use through insurance claims data
ObjectiveTo assess postacute rehabilitation service use and length of stay among a national sample of patients with brain tumors after surgery.DesignA retrospective review was conducted of health care claims data of a national sample of patients via The Optum Clinformatics DataMart.Setting and ParticipantsThis study included adult individuals (>= 18 years of age) who were diagnosed with a brain tumor between 2015 and 2019 and underwent a craniotomy or craniectomy within 180 days of diagnosis.MethodsDescriptive statistics were used to characterize patients by tumor type. Multivariate models assessed factors associated with discharge setting and length of stay.ResultsOf the 10,275 individuals identified, 69% had malignant tumors. Over two thirds of patients were discharged directly home (with or without home health care) and 9.3% and 9.5% were discharged to acute rehabilitation facilities (inpatient rehabilitation facilities [IRF]) and skilled nursing facilities (SNF/ICF), respectively. About 13.5% were discharged to other settings. The average length of stay during the episode of care was 8.6 (SD = 9.6) days. After adjusting for confounders, individuals with benign brain tumors were more likely to be discharged to either IRF or SNF/ICF than return home after acute care stay, as were those with greater comorbidities, older age, fee-for-service and health maintenance organization insurance. Wealthier patients were less likely to be discharged to a SNF/ICF than home, although income was not a factor affecting discharge to an IRF. Patients with benign tumors, the oldest old (80+), those with more comorbidities as well as Black and Hispanic patients had a longer length of stay during the acute hospitalization.ConclusionsIndividuals with brain tumors have deficits amenable to rehabilitation; however, this study finds that service use differs by tumor type and demographic and socioeconomic factors. Further study is needed to identify if there are barriers to access and use of rehabilitation services in this population.
- Open Access
- 6 September 2023
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 105 (21) , 1695-1702
Hemiarthroplasty Versus Total Hip Arthroplasty for Femoral Neck Fracture in Elderly Patients
Background: There is practice variation in the selection of a total hip arthroplasty (THA) or a hemiarthroplasty (HA) for the treatment of displaced femoral neck fractures in elderly patients. Large data sets are needed to compare the rates of rare complications following these procedures. We sought to examine the relationship between surgery type and secondary hip surgery (revision or conversion arthroplasty) at 12 months following the index arthroplasty, and that between surgery type and dislocation at 12 months, among elderly Medicare beneficiaries who underwent THA or HA for a femoral neck fracture, taking into account the potential for selection bias. Methods: We performed a population-based, retrospective study of elderly (>65 years of age) Medicare beneficiaries who underwent THA or HA following a femoral neck fracture. Two-stage, instrumental variable regression models were applied to nationally representative Medicare medical claims data from 2017 to 2019. Results: Of the 61,695 elderly patients who met the inclusion criteria, of whom 74.1% were female and 92.2% were non-Hispanic White, 10,268 patients (16.6%) underwent THA and 51,427 (83.4%) underwent HA. The findings from the multivariable, instrumental variable analyses indicated that treatment of displaced femoral neck fractures with THA was associated with a significantly higher risk of dislocation at 12 months compared with treatment with HA (2.9% for the THA group versus 1.9% for the HA group; p = 0.001). There was no significant difference in the likelihood of 12-month revision/conversion between THA and HA. Conclusions: The use of THA to treat femoral neck fractures in elderly patients is associated with a significantly higher risk of 12-month dislocation, as compared with the use of HA, although the difference may not be clinically important. A low overall rate of dislocation was found in both groups. The risk of revision/conversion at 12 months did not differ between the groups. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 6 September 2023
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 105 (21) , 1695-1702
Open AccessHemiarthroplasty Versus Total Hip Arthroplasty for Femoral Neck Fracture in Elderly Patients
Background: There is practice variation in the selection of a total hip arthroplasty (THA) or a hemiarthroplasty (HA) for the treatment of displaced femoral neck fractures in elderly patients. Large data sets are needed to compare the rates of rare complications following these procedures. We sought to examine the relationship between surgery type and secondary hip surgery (revision or conversion arthroplasty) at 12 months following the index arthroplasty, and that between surgery type and dislocation at 12 months, among elderly Medicare beneficiaries who underwent THA or HA for a femoral neck fracture, taking into account the potential for selection bias. Methods: We performed a population-based, retrospective study of elderly (>65 years of age) Medicare beneficiaries who underwent THA or HA following a femoral neck fracture. Two-stage, instrumental variable regression models were applied to nationally representative Medicare medical claims data from 2017 to 2019. Results: Of the 61,695 elderly patients who met the inclusion criteria, of whom 74.1% were female and 92.2% were non-Hispanic White, 10,268 patients (16.6%) underwent THA and 51,427 (83.4%) underwent HA. The findings from the multivariable, instrumental variable analyses indicated that treatment of displaced femoral neck fractures with THA was associated with a significantly higher risk of dislocation at 12 months compared with treatment with HA (2.9% for the THA group versus 1.9% for the HA group; p = 0.001). There was no significant difference in the likelihood of 12-month revision/conversion between THA and HA. Conclusions: The use of THA to treat femoral neck fractures in elderly patients is associated with a significantly higher risk of 12-month dislocation, as compared with the use of HA, although the difference may not be clinically important. A low overall rate of dislocation was found in both groups. The risk of revision/conversion at 12 months did not differ between the groups. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 4 January 2022
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 104 (6) , 523-529
The Impact of Femoral Component Cementation on Fracture and Mortality Risk in Elective Total Hip Arthroplasty
Background: Complications following elective total hip arthroplasty (THA) are rare but potentially devastating. The impact of femoral component cementation on the risk of periprosthetic femoral fractures and early perioperative death has not been studied in a nationally representative population in the United States. Methods: Elective primary THAs performed with or without cement among elderly patients were identified from Medicare claims from 2017 to 2018. We performed separate nested case-control analyses matched 1:2 on age, sex, race/ethnicity, comorbidities, payment model, census division of facility, and exposure time and compared fixation mode between (1) groups with and without 90-day periprosthetic femoral fracture and (2) groups with and without 30-day mortality. Results: A total of 118,675 THAs were included. The 90-day periprosthetic femoral fracture rate was 2.0%, and the 30-day mortality rate was 0.18%. Cases were successfully matched. The risk of periprosthetic femoral fracture was significantly lower among female patients with cement fixation compared with matched controls with cementless fixation (OR = 0.83; 95% CI, 0.69 to 1.00; p = 0.05); this finding was not evident among male patients (p = 0.94). In contrast, the 30-day mortality risk was higher among male patients with cement fixation compared with matched controls with cementless fixation (OR = 2.09; 95% CI, 1.12 to 3.87; p = 0.02). The association between cement usage and mortality among female patients almost reached significance (OR = 1.74; 95% CI, 0.98 to 3.11; p = 0.06). Conclusions: In elderly patients managed with THA, cemented stems were associated with lower rates of periprosthetic femoral fracture among female patients but not male patients. The association between cemented stems and higher rates of 30-day mortality was significant for male patients and almost reached significance for female patients, although the absolute rates of mortality were very low. For surgeons who can competently perform THA with cement, our data support the use of a cemented stem to avoid periprosthetic femoral fracture in elderly female patients. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 4 January 2022
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 104 (6) , 523-529
The Impact of Femoral Component Cementation on Fracture and Mortality Risk in Elective Total Hip Arthroplasty
Background: Complications following elective total hip arthroplasty (THA) are rare but potentially devastating. The impact of femoral component cementation on the risk of periprosthetic femoral fractures and early perioperative death has not been studied in a nationally representative population in the United States. Methods: Elective primary THAs performed with or without cement among elderly patients were identified from Medicare claims from 2017 to 2018. We performed separate nested case-control analyses matched 1:2 on age, sex, race/ethnicity, comorbidities, payment model, census division of facility, and exposure time and compared fixation mode between (1) groups with and without 90-day periprosthetic femoral fracture and (2) groups with and without 30-day mortality. Results: A total of 118,675 THAs were included. The 90-day periprosthetic femoral fracture rate was 2.0%, and the 30-day mortality rate was 0.18%. Cases were successfully matched. The risk of periprosthetic femoral fracture was significantly lower among female patients with cement fixation compared with matched controls with cementless fixation (OR = 0.83; 95% CI, 0.69 to 1.00; p = 0.05); this finding was not evident among male patients (p = 0.94). In contrast, the 30-day mortality risk was higher among male patients with cement fixation compared with matched controls with cementless fixation (OR = 2.09; 95% CI, 1.12 to 3.87; p = 0.02). The association between cement usage and mortality among female patients almost reached significance (OR = 1.74; 95% CI, 0.98 to 3.11; p = 0.06). Conclusions: In elderly patients managed with THA, cemented stems were associated with lower rates of periprosthetic femoral fracture among female patients but not male patients. The association between cemented stems and higher rates of 30-day mortality was significant for male patients and almost reached significance for female patients, although the absolute rates of mortality were very low. For surgeons who can competently perform THA with cement, our data support the use of a cemented stem to avoid periprosthetic femoral fracture in elderly female patients. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 15 January 2021
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 72 (Supplement) , S1-S7
Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units
The key epidemiological drivers of Clostridioides difficile transmission are not well understood. We estimated epidemiological parameters to characterize variation in C. difficile transmission, while accounting for the imperfect nature of surveillance tests. We conducted a retrospective analysis of C. difficile surveillance tests for patients admitted to a bone marrow transplant (BMT) unit or a solid tumor unit (STU) in a 565-bed tertiary hospital. We constructed a transmission model for estimating key parameters, including admission prevalence, transmission rate, and duration of colonization to understand the potential variation in C. difficile dynamics between these 2 units. A combined 2425 patients had 5491 admissions into 1 of the 2 units. A total of 3559 surveillance tests were collected from 1394 patients, with 11% of the surveillance tests being positive for C. difficile. We estimate that the transmission rate in the BMT unit was nearly 3-fold higher at 0.29 acquisitions per percentage colonized per 1000 days, compared to our estimate in the STU (0.10). Our model suggests that 20% of individuals admitted into either the STU or BMT unit were colonized with C. difficile at the time of admission. In contrast, the percentage of surveillance tests that were positive within 1 day of admission to either unit for C. difficile was 13.4%, with 15.4% in the STU and 11.6% in the BMT unit. Although prevalence was similar between the units, there were important differences in the rates of transmission and clearance. Influential factors may include antimicrobial exposure or other patient-care factors.
- 15 January 2021
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 72 (Supplement) , S1-S7
Open AccessTransmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units
The key epidemiological drivers of Clostridioides difficile transmission are not well understood. We estimated epidemiological parameters to characterize variation in C. difficile transmission, while accounting for the imperfect nature of surveillance tests. We conducted a retrospective analysis of C. difficile surveillance tests for patients admitted to a bone marrow transplant (BMT) unit or a solid tumor unit (STU) in a 565-bed tertiary hospital. We constructed a transmission model for estimating key parameters, including admission prevalence, transmission rate, and duration of colonization to understand the potential variation in C. difficile dynamics between these 2 units. A combined 2425 patients had 5491 admissions into 1 of the 2 units. A total of 3559 surveillance tests were collected from 1394 patients, with 11% of the surveillance tests being positive for C. difficile. We estimate that the transmission rate in the BMT unit was nearly 3-fold higher at 0.29 acquisitions per percentage colonized per 1000 days, compared to our estimate in the STU (0.10). Our model suggests that 20% of individuals admitted into either the STU or BMT unit were colonized with C. difficile at the time of admission. In contrast, the percentage of surveillance tests that were positive within 1 day of admission to either unit for C. difficile was 13.4%, with 15.4% in the STU and 11.6% in the BMT unit. Although prevalence was similar between the units, there were important differences in the rates of transmission and clearance. Influential factors may include antimicrobial exposure or other patient-care factors.
- Open Access
- 1 January 2020
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 5 (4) , e20.00126
In-Bundle Surgeons More Likely Select Cemented Femoral Fixation in Total Hip Arthroplasty for At-Risk Patients
Background: Bundled payment models for lower-extremity arthroplasty have been shown to lower costs but have not reliably improved quality. It is unknown how the bundled payment model may affect surgeons’ decisions that impact the quality of arthroplasty care. The purpose of this study was to compare the utilization of femoral component fixation modes by surgeons performing total hip arthroplasties (THAs) in at-risk patients in areas subject to Medicare’s Comprehensive Care for Joint Replacement (CJR) bundled payment model compared with patients treated by surgeons in areas exempt from the policy. Methods: Elective, primary THAs among elderly persons were identified from Medicare claims during 2017 and 2018, including the use of cemented or cementless femoral fixation. Multivariable regression models, applied to samples stratified by sex, were used to assess the association between CJR bundle participation and the use of femoral fixation mode. Analyses were adjusted for patient age, race or ethnicity, comorbidity burden, low-income status, and Census division of the hospital. Results: Of 118,676 Medicare patients who underwent THA, 9.1% received cemented femoral components, and use of cement varied significantly by geographic region (p < 0.001). Patients who received cemented fixation, compared with patients who received cementless fixation, had significant differences in mean age (and standard deviation) at 78.3 ± 6.9 years compared with 74.5 ± 6.1 years (p < 0.001) for female patients and 77.3 ± 6.8 years and 74.2 ± 5.9 years (p < 0.001) for male patients; were more likely to be White at 94.0% compared with 92.7% (p < 0.001) for female patients and 95.1% compared with 93.8% (p = 0.046) for male patients; and had higher mean Elixhauser comorbidity index at 2.6 ± 2.2 compared with 2.3 ± 2.0 (p < 0.001) for female patients and 2.8 ± 2.4 compared with 2.4 ± 2.1 (p < 0.001) for male patients. In adjusted analyses, female patients in the CJR bundled payment model were more likely to have cemented fixation compared with female patients not in the CJR model (odds ratio [OR], 1.11 [95% confidence interval (CI), 1.05 to 1.16]; p < 0.001), whereas male patients in the CJR bundled payment model were less likely to have cemented fixation compared with male patients not in the CJR model (OR, 0.91 [95% CI, 0.83 to 0.99]; p = 0.029). Conclusions: In the bundled environment, surgeons were more likely to choose cemented femoral fixation for elderly female patients. This may be due to in-bundle surgeons being more risk-averse and avoiding cementless fixation in patients at risk for fracture or implant-related complications. Further research is needed to directly examine the impact of the bundle on surgeon decision-making.
- 1 January 2020
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 5 (4) , e20.00126
Open AccessIn-Bundle Surgeons More Likely Select Cemented Femoral Fixation in Total Hip Arthroplasty for At-Risk Patients
Background: Bundled payment models for lower-extremity arthroplasty have been shown to lower costs but have not reliably improved quality. It is unknown how the bundled payment model may affect surgeons’ decisions that impact the quality of arthroplasty care. The purpose of this study was to compare the utilization of femoral component fixation modes by surgeons performing total hip arthroplasties (THAs) in at-risk patients in areas subject to Medicare’s Comprehensive Care for Joint Replacement (CJR) bundled payment model compared with patients treated by surgeons in areas exempt from the policy. Methods: Elective, primary THAs among elderly persons were identified from Medicare claims during 2017 and 2018, including the use of cemented or cementless femoral fixation. Multivariable regression models, applied to samples stratified by sex, were used to assess the association between CJR bundle participation and the use of femoral fixation mode. Analyses were adjusted for patient age, race or ethnicity, comorbidity burden, low-income status, and Census division of the hospital. Results: Of 118,676 Medicare patients who underwent THA, 9.1% received cemented femoral components, and use of cement varied significantly by geographic region (p < 0.001). Patients who received cemented fixation, compared with patients who received cementless fixation, had significant differences in mean age (and standard deviation) at 78.3 ± 6.9 years compared with 74.5 ± 6.1 years (p < 0.001) for female patients and 77.3 ± 6.8 years and 74.2 ± 5.9 years (p < 0.001) for male patients; were more likely to be White at 94.0% compared with 92.7% (p < 0.001) for female patients and 95.1% compared with 93.8% (p = 0.046) for male patients; and had higher mean Elixhauser comorbidity index at 2.6 ± 2.2 compared with 2.3 ± 2.0 (p < 0.001) for female patients and 2.8 ± 2.4 compared with 2.4 ± 2.1 (p < 0.001) for male patients. In adjusted analyses, female patients in the CJR bundled payment model were more likely to have cemented fixation compared with female patients not in the CJR model (odds ratio [OR], 1.11 [95% confidence interval (CI), 1.05 to 1.16]; p < 0.001), whereas male patients in the CJR bundled payment model were less likely to have cemented fixation compared with male patients not in the CJR model (OR, 0.91 [95% CI, 0.83 to 0.99]; p = 0.029). Conclusions: In the bundled environment, surgeons were more likely to choose cemented femoral fixation for elderly female patients. This may be due to in-bundle surgeons being more risk-averse and avoiding cementless fixation in patients at risk for fracture or implant-related complications. Further research is needed to directly examine the impact of the bundle on surgeon decision-making.
- Open Access
The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence
Background: One‐third to one‐half of patients prescribed adjuvant endocrine therapy are nonadherent during the recommended 5‐year endocrine therapy course. This study investigated whether poor pharmacy synchronization of medication fills (requiring refills on different days) acts as a barrier to adherence.Methods: A cohort of older women with stage 0 to III endocrine receptor–positive breast cancer in 2011 was identified from the Surveillance, Epidemiology, and End Result–Medicare claims‐linked cancer registry. Women with endocrine therapy and at least 1 other medication fill were identified, and the 3‐month synchronization of their fills was calculated as 1 minus the quotient of the number of pharmacy visits and the number of filled medications. Regression models were used to examine the association between synchronization (in quartiles adjusted for the number of medications) and adherence to endocrine therapy (defined as a medication possession ratio ≥80%) over the subsequent year.Results: During the 3 months after the first endocrine therapy prescription, the study cohort of 3212 women had a mean of 8.6 pharmacy visits (standard deviation, 4.7) with a mean synchronization of 0.3 (standard deviation, 0.2). Those in the third (odds ratio, 1.29; 95% confidence interval, 1.04‐1.59) and fourth (most) medication number–adjusted synchronization quartiles (odds ratio, 1.49; 95% confidence interval, 1.19‐1.86) were more likely to be adherent than those in the least. Multivariate model predictions showed that the proportion of patients who were adherent over 1 year varied from 68.9% in the least synchronized quartile to 76.6% in the most synchronized one.Conclusions: Prescription refill synchronization is strongly associated with adherence to endocrine therapy. Efforts to improve adherence should address this.
Open AccessThe association of pharmacy fill synchronization with breast cancer endocrine therapy adherence
Background: One‐third to one‐half of patients prescribed adjuvant endocrine therapy are nonadherent during the recommended 5‐year endocrine therapy course. This study investigated whether poor pharmacy synchronization of medication fills (requiring refills on different days) acts as a barrier to adherence.Methods: A cohort of older women with stage 0 to III endocrine receptor–positive breast cancer in 2011 was identified from the Surveillance, Epidemiology, and End Result–Medicare claims‐linked cancer registry. Women with endocrine therapy and at least 1 other medication fill were identified, and the 3‐month synchronization of their fills was calculated as 1 minus the quotient of the number of pharmacy visits and the number of filled medications. Regression models were used to examine the association between synchronization (in quartiles adjusted for the number of medications) and adherence to endocrine therapy (defined as a medication possession ratio ≥80%) over the subsequent year.Results: During the 3 months after the first endocrine therapy prescription, the study cohort of 3212 women had a mean of 8.6 pharmacy visits (standard deviation, 4.7) with a mean synchronization of 0.3 (standard deviation, 0.2). Those in the third (odds ratio, 1.29; 95% confidence interval, 1.04‐1.59) and fourth (most) medication number–adjusted synchronization quartiles (odds ratio, 1.49; 95% confidence interval, 1.19‐1.86) were more likely to be adherent than those in the least. Multivariate model predictions showed that the proportion of patients who were adherent over 1 year varied from 68.9% in the least synchronized quartile to 76.6% in the most synchronized one.Conclusions: Prescription refill synchronization is strongly associated with adherence to endocrine therapy. Efforts to improve adherence should address this.
- 1 February 2019
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 100 (2) , 289-299
Patient Satisfaction and Perceived Quality of Care Among Younger Medicare Beneficiaries According to Activity Limitation Stages
- 1 February 2019
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 100 (2) , 289-299
Patient Satisfaction and Perceived Quality of Care Among Younger Medicare Beneficiaries According to Activity Limitation Stages